Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer

Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer

Objective: To guide the optimal selection among first-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in clinical practice. This review attempted to provide a thorough comparison among three first-generation EGFR-TKIs, namely icotinib, erlotinib, and gefitinib, wit...

Full description

Bibliographic Details
Main Authors:	Jun Ni, Li Zhang
Format:	Article
Language:	English
Published:	Wolters Kluwer 2016-01-01
Series:	Chinese Medical Journal
Subjects:	Advanced Nonsmall Cell Lung Cancer; Epithelial Growth Factor Receptor; Optimal Selection; Tyrosine Kinase Inhibitors
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=3;spage=332;epage=340;aulast=Ni

Similar Items

Role of gender in the survival of surgical patients with nonsmall cell lung cancer
by: Nóris C Scaglia, et al.
Published: (2013-01-01)

Feasibility of molecular testing in a multicenter study with geographical variation in India: Epidermal growth factor receptor mutation as a model molecular test
by: Kumar Prabhash, et al.
Published: (2017-01-01)

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
by: J.B. Sorensen, et al.
Published: (2011-03-01)

The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
by: C.L. Watkins, et al.
Published: (2010-09-01)

Proteasome inhibitors in the treatment of nonsmall cell lung cancer: A systematic review of clinical evidence
by: Alethea Dasha Wenning Chua, et al.
Published: (2023-11-01)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
by: Arafat Tfayli, et al.
Published: (2020-11-01)

Disparate outcomes in nonsmall cell lung cancer by immigration status
by: Brittney Chau, et al.
Published: (2021-04-01)

Comparative study of death-associated protein kinase promoter methylation between nonsquamous and squamous subtypes of nonsmall cell lung cancer
by: Fatma A Hisham, et al.
Published: (2021-01-01)

Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature
by: Monalisa Hui, et al.
Published: (2018-01-01)

Analysis of adverse drug reactions of Osimertinib in the 2nd‐line treatment of EGFR mutant advanced nonsmall cell lung cancer
by: Yingying Jiang, et al.
Published: (2022-06-01)

Immunohistochemistry and fluorescence in-situ hybridization study for detection of anaplastic lymphoma kinase gene rearrangement in nonsmall cell lung carcinoma
by: Mohamed Hantera, et al.
Published: (2018-01-01)

Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer
by: Seo Yun Kim, et al.
Published: (2017-01-01)

Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy
by: Koulouris A., et al.
Published: (2023-10-01)

Identifying Prognostic Groups Using Machine Learning Tools in Patients Undergoing Chemoradiation for Inoperable Locally Advanced Nonsmall Cell Lung Carcinoma
by: Anjali K. Pahuja, et al.
Published: (2019-07-01)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
by: Vanita Noronha, et al.
Published: (2020-01-01)

The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis
by: Chutong Lin, et al.
Published: (2021-04-01)

The clinical outcome of brain metastases in nonsmall cell lung cancer patients with epidermal growth factor receptor mutation- A retrospective single-institution analysis
by: Cho-Hao Lee, et al.
Published: (2018-01-01)

Management of lung cancer brain metastasis: An overview
by: Himanshu Srivastava, et al.
Published: (2017-07-01)

The pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer: A retrospective study
by: Abdulrahman M Jazieh, et al.
Published: (2018-01-01)

Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait
by: Rabeah Al-Temaimi, et al.
Published: (2016-01-01)

Impact of symptom clusters on quality of life outcomes in patients from japan with advanced nonsmall cell lung cancers
by: Tamami Hamada, et al.
Published: (2016-01-01)

Life‐threatening pneumonitis after first‐line treatment with osimertinib for primary T790M mutated non‐small cell lung cancer
by: Maik Häntschel, et al.
Published: (2020-07-01)

Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
by: Gee-Chen Chang, et al.
Published: (2013-09-01)

Efficacy and Safety of Albumin-bound Paclitaxel  in Treating Recurrent Advanced Non-small Cell Lung Cancer
by: Puyuan XING, et al.
Published: (2013-10-01)

Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
by: Laksmi Wulandari, et al.
Published: (2018-07-01)

Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
by: Kumar Prabhash
Published: (2019-01-01)

Current therapy and development of therapeutic agents for lung cancer
by: Zilai Wang, et al.
Published: (2022-04-01)

Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage I and II Nonsmall Cell Lung Cancer
by: Yu-Ning Liu, et al.
Published: (2016-01-01)

Inhibition of Nonsmall Cell Lung Cancer Cell Migration by Protein Arginine Methyltransferase 1-small Hairpin RNA Through Inhibiting Epithelial-mesenchymal Transition, Extracellular Matrix Degradation, and Src Phosphorylation In Vitro
by: Ting Zhang, et al.
Published: (2015-01-01)

Research Progress of Small Molecule Anti-angiogenic Drugs  in Non-small Cell Lung Cancer
by: Yan DOU, et al.
Published: (2021-01-01)

Clinical Observation of EGFR-TKI as A First-line Therapy on Advanced Non-small Cell Lung Cancer
by: Jianjie LI, et al.
Published: (2012-05-01)

Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer
by: Hua-Ye Zhao, et al.
Published: (2016-01-01)

Comparison between next‐generation sequencing and multiplex polymerase chain reaction assays for nonsmall‐cell lung cancer molecular diagnosis
by: Shuji Murakami, et al.
Published: (2024-04-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017-01-01)

Advances in Antiangiogenic Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in 2017 ASCO and WCLC
by: Lianfang NI, et al.
Published: (2018-05-01)

Molecular epidemiological study of microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene using immunohistochemistry as a cost effective alternative to fluorescence in situ hybridization for Indian patients with adenocarcinoma lung
by: Anurag Mehta, et al.
Published: (2017-01-01)

Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer
by: Renhua GUO, et al.
Published: (2009-12-01)

HIP1R Expression and Its Association with PD-1 Pathway Blockade Response in Refractory Advanced NonSmall Cell Lung Cancer: A Gene Set Enrichment Analysis
by: Young Wha Koh, et al.
Published: (2020-05-01)

Clinicopathological Characteristics and Real-life Data of Patients Receiving Tyrosine Kinase Inhibitor in Metastatic EGFR Mutant Non-small Cell Lung Carcinoma
by: Barış EKİNCİ, et al.
Published: (2023-12-01)